MedPath

The Mind Research Network

The Mind Research Network logo
🇺🇸United States
Ownership
Subsidiary
Established
1998-01-01
Employees
251
Market Cap
-
Website
http://www.mrn.org

Modafinil for the Treatment of Alcohol Use Disorders

Phase 2
Completed
Conditions
Alcohol Use Disorder
Interventions
Other: Placebo
Drug: Modafinil
First Posted Date
2018-02-07
Last Posted Date
2020-05-26
Lead Sponsor
The Mind Research Network
Target Recruit Count
12
Registration Number
NCT03424681
Locations
🇺🇸

Mind Research Network, Albuquerque, New Mexico, United States

TDCS and Cognitive Retraining to Augment Pharmacotherapy for the Treatment of Nicotine Dependence

Not Applicable
Completed
Conditions
Nicotine Dependence
Interventions
Behavioral: Active Retraining
Behavioral: Sham Retraining
Device: Active transcranial direct current stimulation (TDCS)
Device: Sham transcranial direct current stimulation (TDCS)
Drug: Nicotine Replacement Therapy (Habitrol)
First Posted Date
2015-08-27
Last Posted Date
2018-05-17
Lead Sponsor
The Mind Research Network
Target Recruit Count
86
Registration Number
NCT02534454
Locations
🇺🇸

The Mind Research Network, Albuquerque, New Mexico, United States

Cognitive Retraining and Brain Stimulation for Alcohol Use

Not Applicable
Completed
Conditions
Binge Drinking
Interventions
Behavioral: Active Retraining
Device: Active TDCS
Behavioral: Sham Retraining
Device: Sham TDCS
First Posted Date
2014-01-24
Last Posted Date
2018-03-20
Lead Sponsor
The Mind Research Network
Target Recruit Count
77
Registration Number
NCT02045108
Locations
🇺🇸

The Mind Research Network and University of New Mexico Center on Alcoholism, Substance Abuse and Addiction, Albuquerque, New Mexico, United States

Effects of Sulfasalazine on BOLD Response to Alcohol Cues

Not Applicable
Completed
Conditions
Alcohol Dependence
Interventions
Drug: Sulfasalazine
Drug: Placebo
First Posted Date
2011-03-10
Last Posted Date
2014-09-22
Lead Sponsor
The Mind Research Network
Target Recruit Count
23
Registration Number
NCT01312129
Locations
🇺🇸

The Mind Research Network, Albuquerque, New Mexico, United States

Effectiveness of Varenicline: Testing Individual Differences

Phase 4
Completed
Conditions
Smoking Addiction
Interventions
Drug: Varenicline
Drug: Placebo
First Posted Date
2010-10-26
Last Posted Date
2018-05-09
Lead Sponsor
The Mind Research Network
Target Recruit Count
218
Registration Number
NCT01228175
Locations
🇺🇸

The Mind Research Network, Albuquerque, New Mexico, United States

A New Pharmacotherapy for Alcohol Dependence: Olanzapine

Phase 3
Completed
Conditions
Alcohol Dependence
Interventions
Drug: 2.5 mg Olanzapine
Drug: 5mg Olanzapine
Drug: placebo
First Posted Date
2008-09-04
Last Posted Date
2014-03-20
Lead Sponsor
The Mind Research Network
Target Recruit Count
304
Registration Number
NCT00746785
Locations
🇺🇸

The Mind Research Network, Albuquerque, New Mexico, United States

© Copyright 2025. All Rights Reserved by MedPath